Cargando…
The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth
It is well established that Cholangiocarcioma (CCA) drug resistance plays a crucial role in the spread and survival of cancer cells. The major enzyme in the nicotinamide-adenine dinucleotide (NAD+)-mediated pathways, nicotinamide phosphoribosyltransferase (NAMPT), is essential for cancer cell surviv...
Autores principales: | Pant, Kishor, Richard, Seth, Peixoto, Estanislao, Yin, Jun, Seelig, Davis M., Carotenuto, Pietro, Salati, Massimiliano, Franco, Brunella, Roberts, Lewis R., Gradilone, Sergio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001024/ https://www.ncbi.nlm.nih.gov/pubmed/36899911 http://dx.doi.org/10.3390/cells12050775 |
Ejemplares similares
-
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury
por: Esposito, Emanuela, et al.
Publicado: (2012) -
A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT
por: Barraud, Marine, et al.
Publicado: (2016) -
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
por: Parisotto, Maxime, et al.
Publicado: (2022) -
Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
por: Pant, Kishor, et al.
Publicado: (2020) -
Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
por: Pant, Kishor, et al.
Publicado: (2020)